11 January 2011

IFCI research, Equity Buy/Sell (Technical View) 11/1/11

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Equity Buy/Sell (Technical View)
Ø  Alongwith Nifty, many scrips are also crucially poised like Canara Bk. HDFC, ICICI, SBI in bank sector as also many scrips across sectors.
Ø  Wipro, Mphasis in tech sector are expected to reverse up shortly. TCS and Infosys can be accumulated on further reactions.
Ø  Health care is also reacting and will be an opportunity to buy good scrips. One such scrip is Glaxo which has good support around 2100 and then 2000.
Ø  Investors can buy a portion at these support levels.
Ø  We will wait for a session or two more and advise investors for opportunities to invest across sectors.

Have Strict Stop Loss

No comments:

Post a Comment